Related Experiment Video
Updated: Jul 29, 2025
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
309
Recurrence and Postoperative Death in Patients with Colorectal Cancer: A New Perspective via Semi-competing Risk
Malihe Safari1, Leila Mahmoudi2, Emma K Baker3
1Department of Biostatistics, Arak University of Medical Sciences Faculty of Medicine, Arak, Iran.
Summary
This study used a semi-competing risk approach to identify predictors of recurrence and death in colorectal cancer patients. Metastasis and higher pathological node stage increased recurrence and death risk, while fewer chemotherapies reduced death risk without recurrence.
Area of Science:
- Oncology
- Biostatistics
- Clinical Research
Background:
- Cancer survival prediction is often overestimated when both recurrence and death are considered.
- A semi-competing risk approach is crucial for accurately evaluating outcomes in longitudinal cancer studies.
Purpose of the Study:
- To mitigate survival prediction overestimation in colorectal cancer studies.
- To identify factors influencing recurrence and postoperative death using a semi-competing risk model.
Main Methods:
- A longitudinal prospective study involving 284 resected colorectal cancer patients.
- Utilized a semi-competing risk approach to analyze time to recurrence, time to death, and time to death after recurrence.
- Assessed the relationship between demographics, clinical factors, and outcomes.
Main Results:
- Metastasis and higher pathological node (pN) stage significantly increased the hazard of recurrence.
- Higher pN stages were associated with increased hazard of death after recurrence.
- Fewer chemotherapies and higher pN stages were linked to higher hazards of death without recurrence.
Conclusions:
- Findings highlight specific predictors for death and recurrence in colorectal cancer.
- Tailored preventive and interventional strategies are recommended for managing patient outcomes.
- The study emphasizes the importance of considering semi-competing risks in cancer research.
More Related Videos
Related Concept Videos
01:21Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
01:12Relative Risk
251
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
251
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
151
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
151
01:20Comparing the Survival Analysis of Two or More Groups
229
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
229
01:15Assumptions of Survival Analysis
163
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
163
01:24Kaplan-Meier Approach
200
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
200